| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/19/2007 | WO2007044449A2 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 04/19/2007 | WO2007044437A2 Octanol formulations and methods of treatment using the same |
| 04/19/2007 | WO2007044435A2 Treatment of peripheral arterial occlusive disease |
| 04/19/2007 | WO2007044426A2 Pyrazolopyrimidines as protein kinase inhibitors |
| 04/19/2007 | WO2007044420A1 Pyrazolopyrimidines as cyclin dependent kinase inhibitors for the treatment of cancer |
| 04/19/2007 | WO2007044410A1 Pyrazolo [1,5-a] pyrimidines as protein kinase inhibitors |
| 04/19/2007 | WO2007044407A2 Pyrazolo (1 , 5a) pyrimidines as protein kinase inhibitors |
| 04/19/2007 | WO2007044401A2 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 04/19/2007 | WO2007044357A2 Formulations of aica riboside |
| 04/19/2007 | WO2007044348A2 Anti-infective hygiene products based on cellulose acetate phthalate |
| 04/19/2007 | WO2007044325A2 Apoe4 domain interaction inhibitors and methods of use thereof |
| 04/19/2007 | WO2007044309A2 Device and method for inhibiting age complex formation |
| 04/19/2007 | WO2007044215A1 Hexahydro cyclooctyl pyrazole cannabinoid modulators |
| 04/19/2007 | WO2007044180A2 Improved toleration iron supplement compositions |
| 04/19/2007 | WO2007044084A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 04/19/2007 | WO2007044015A1 Treating or preventing renal cancer using a dimethane sulfonate |
| 04/19/2007 | WO2007043939A1 Novel crystalline form of 3,5-dibromo-n- [(2s)-2-(-4-fluorophenyl)-4-(3-morpholin-4-ylazetidin-1-yl)butyl] -n-methylbenzamide, modification a |
| 04/19/2007 | WO2007043938A1 NOVEL CRYSTALLINE FORM OF 3,5-DIBROMO-N- [ (2S) -2- (-4- FLUOROPHENYL) -4- (3-MORPHOLIN-4-YLAZTIDIN-l-YL) BUTYL] -N METHYLBENZAMIDE, MODIFICATION B |
| 04/19/2007 | WO2007043870A1 Leucine rich composition |
| 04/19/2007 | WO2007043853A1 Pharmaceutical compositions comprising combined antidiabetic substances for use in diabetes mellitus |
| 04/19/2007 | WO2007043715A1 Rna-binding peptide |
| 04/19/2007 | WO2007043710A1 Novel dihydropseudoerythromycin derivatives |
| 04/19/2007 | WO2007043702A1 Agent for applying to mucosa and method for production thereof |
| 04/19/2007 | WO2007043653A1 Benzimidazole-5-carboxamide derivative |
| 04/19/2007 | WO2007043652A1 2-thienylurea derivative |
| 04/19/2007 | WO2007043640A1 Substance for use in treatment or prevention of hcv infection |
| 04/19/2007 | WO2007043638A1 Condensed heterocyclic compound |
| 04/19/2007 | WO2007043606A1 Antidiabetic agent comprising anionic polyamino acid-metal complex |
| 04/19/2007 | WO2007043581A1 Thienopyridine-2-carboxamide derivative |
| 04/19/2007 | WO2007043580A1 Iontophoresis preparation for treatment of breast cancer and/or mastitis |
| 04/19/2007 | WO2007043568A1 S1p3 receptor antagonist |
| 04/19/2007 | WO2007043563A1 Composition for improving intestinal flora |
| 04/19/2007 | WO2007043542A1 Antituberculous composition comprising oxazole compounds |
| 04/19/2007 | WO2007043538A1 Composition for oral administration |
| 04/19/2007 | WO2007043518A1 Therapeutic agent for nausea and/or vomiting |
| 04/19/2007 | WO2007043457A1 Triarylcarboxylic acid derivative |
| 04/19/2007 | WO2007043433A1 Therapeutic agent for liver disease containing 2-amino-1,3-propanediol derivative as active ingredient and therapeutic method for liver disease |
| 04/19/2007 | WO2007043426A1 Dermatitis remedies |
| 04/19/2007 | WO2007043401A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | WO2007043400A1 Nitrogenated aromatic heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | WO2007043365A1 Therapeutic agent for neurogenic pain |
| 04/19/2007 | WO2007043363A1 Composition for use in prevention of hypoglycemic condition |
| 04/19/2007 | WO2007043306A1 Agent for amelioration of insulin resistance |
| 04/19/2007 | WO2007043305A1 Agent for amelioration of insulin resistance |
| 04/19/2007 | WO2007043302A1 Agent for amelioration of insulin resistance |
| 04/19/2007 | WO2007043294A1 Visceral fat accumulation inhibitor |
| 04/19/2007 | WO2007043094A2 6-vinyl pyrimidine and pyrimidinone derivatives and the use thereof |
| 04/19/2007 | WO2007043061A1 Anti-malarial combination and methods of formulation |
| 04/19/2007 | WO2007043058A1 Process for producing enriched fractions of tetrahydroxycurcumin and tetrahydrotetrahydroxy-curcumin from the extracts of curcuma longa |
| 04/19/2007 | WO2007043049A1 Compositions for silencing the expression of vdac1 and uses thereof |
| 04/19/2007 | WO2007043046A2 Carotenoid oxidation products as chemopreventive and chemotherapeutic agents |
| 04/19/2007 | WO2007042983A2 Fluridone as an anti-inflammatory agent |
| 04/19/2007 | WO2007042917A1 Crystalline sodium salt of cephalosporin antibiotic |
| 04/19/2007 | WO2007042912A2 Heterocyclic compounds as pstat3/il-6 inhibitors |
| 04/19/2007 | WO2007042910A1 Imidazoles and their use as hmg-coa reductase inhibitors |
| 04/19/2007 | WO2007042902A2 Extracts from nyctanthes arbortristis for the treatement of leishmaniasis |
| 04/19/2007 | WO2007042899A2 Human microrna targets in hiv genome and a method of identification thereof |
| 04/19/2007 | WO2007042883A1 Inhibitors of the hiv integrase enzyme |
| 04/19/2007 | WO2007042827A2 Treatment and diagnosis of obligate intracellular pathogens |
| 04/19/2007 | WO2007042817A1 Naphthalene-disulfonamides useful for the treatment of inflammation |
| 04/19/2007 | WO2007042816A1 Benzoxazoles useful in the treatment of inflammation |
| 04/19/2007 | WO2007042815A1 Compounds containing more than one human neutrophil elastase inhibiting moiety for use in the treatment of respiratory diseases |
| 04/19/2007 | WO2007042811A1 Pharmaceutical compositions for the treatment of chronic obstructive pulmonary disease |
| 04/19/2007 | WO2007042810A1 Pyrimidine derivatives for the treatment of cancer |
| 04/19/2007 | WO2007042806A1 Pyrimidine derivatives for the treatment of cancer |
| 04/19/2007 | WO2007042799A1 Novel crystalline forms |
| 04/19/2007 | WO2007042786A2 4 -heteroaryl pyrimidine derivatives and use thereof as protein kinase inhibitors |
| 04/19/2007 | WO2007042784A2 Pyrimidin-4-yl-3, 4-dihydr0-2h- pyrrolo [1, 2a] pyrazin-1-one compounds |
| 04/19/2007 | WO2007042782A1 Chemical compounds |
| 04/19/2007 | WO2007042776A1 Modulators of the purinergic signalling pathway for treating sodium homeostatsis, hypertension and aldosteronism |
| 04/19/2007 | WO2007042745A1 Chocolate based appetite suppressant |
| 04/19/2007 | WO2007042682A1 Pharmaceutical composition based on a morpholinic antimycotic agent and a water-soluble film-forming agent for ungual and periungual application |
| 04/19/2007 | WO2007042669A2 Derivatives of 4-amino-quinazoline, preparation method thereof and use of same in therapeutics |
| 04/19/2007 | WO2007042668A1 Derivatives of 1-amino-isoquinoline, preparation method thereof and use of same in therapeutics in the treatment of a dysfunction associated with mch receptor 1 |
| 04/19/2007 | WO2007042660A2 Substituted 1-amino-phthalzine derivatives, preparation and therapeutic use thereof |
| 04/19/2007 | WO2007042657A1 $g(d)d crystalline form of ivabradine hydrochloride, preparation method thereof and pharmaceutical compositions containing same |
| 04/19/2007 | WO2007042656A1 Delta crystalline form of ivabradine hydrochloride, preparation method thereof and pharmaceutical compositions containing same |
| 04/19/2007 | WO2007042647A1 Erythrocytes containing 5-fluorouracil (5-fu) and/or oxaliplatinum |
| 04/19/2007 | WO2007042572A1 Chitosan and heparin nanoparticles |
| 04/19/2007 | WO2007042571A1 Novel pyrimidine-2,4-diamine derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 04/19/2007 | WO2007042554A2 Methods and compositions for treating immune disorders |
| 04/19/2007 | WO2007042546A1 Imidazole derivatives for the treatment of anxiety and related diseases |
| 04/19/2007 | WO2007042545A1 Imidazole derivatives and their use for modulating the gaba-a receptor complex |
| 04/19/2007 | WO2007042544A2 Imidazole derivatives and their use for modulating the gabaa receptor complex |
| 04/19/2007 | WO2007042543A2 Imidazole derivatives and their use for modulating the gaba-a receptor complex |
| 04/19/2007 | WO2007042472A1 Synergistic mixtures of bisabolol and ginger extract |
| 04/19/2007 | WO2007042467A1 Novel pharmaceutical combinations for the treatment of respiratory disorders |
| 04/19/2007 | WO2007042430A1 Regimen of administration for 5-(2-chlorophenyl)-1 ,2-dihydro-7-fluoro-8-methoxy-3-methyl-pyrazolo [3, 4.-b] [1, 4] benzodiazepine |
| 04/19/2007 | WO2007042421A1 Imidazo benzodiazepine derivatives |
| 04/19/2007 | WO2007042420A1 Isoxazole derivatives |
| 04/19/2007 | WO2007042325A1 Antibacterial active 5-chinolin derivative |
| 04/19/2007 | WO2007042321A2 Kinase inhibitors |
| 04/19/2007 | WO2007042299A1 Pyrrolopyrimidine derivatives as syk inhibitors |
| 04/19/2007 | WO2007042298A1 Pyrrolopyrimidine derivatives as syk inhibitors |
| 04/19/2007 | WO2007042296A1 Use of estradiol valerate or estradiol combined with dienogest for the oral therapy of dysfunctional uterine bleeding in the form of oral contraceptives |
| 04/19/2007 | WO2007042295A1 3, 5-disubstituted phenyl-piperidines as mdulators of dopamine? neurotransmission |
| 04/19/2007 | WO2007042272A2 Use of a nutraceutical composition comprising resveratrol for the treatment of age-related diseases |
| 04/19/2007 | WO2007042271A2 Nutraceutical composition for the treatment of muscle wasting |
| 04/19/2007 | WO2007042250A1 Prolinamide derivatives as sodium channel modulators |
| 04/19/2007 | WO2007042240A1 Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels |